<DOC>
	<DOCNO>NCT02904317</DOCNO>
	<brief_summary>Objective : To compare efficacy safety misoprostol vaginal insert ( MVI ) off-label use oral misoprostol ( OM ) . Design : Pair-matched case-control study . Setting : Tertiary-care academic centre Germany . Population : A cohort 138 woman ≥ 37/0 week pregnant undergoing labour induction . Methods : The induction labour retrievable prostaglandin vaginal insert consecutive series 69 woman compare induction use oral misoprostol pair-matched cohort . Main outcome measure : The primary outcome time induction delivery caesarean section rate . Secondary outcome include uterine tachysystole , tocolysis , fetal scalp blood testing , meconium-stained amniotic fluid , umbilical arterial pH , Apgar score .</brief_summary>
	<brief_title>Misoprostol Labour Induction</brief_title>
	<detailed_description>Open , non-interventional study tertiary referral center Germany N/A The rationale observational study describe efficacy safety profile drug definition active labor accord local clinical practice descriptive observational study tertiary referral center . A time interval induction labor delivery depend duration MISODEL® application . By observational study investigator want describe efficacy safety regard time delivery complication rate . Primary Objective : The aim study describe time vaginal delivery definition active labor accord local clinical practice . The time period need induce delivery describe drug safety profile . Primary endpoint : - Time vaginal delivery hour patient vaginal delivery . - Length time delivery - Caesarean section rate - Time onset labor - Frequency vaginal operative delivery - Frequency abnormal CTG ( Figo ) - Frequency uterine Tachysystole lead abnormal fetal heartrate i.e . Figo P. Tachysystole define five contraction 10 minute average three consecutive 10-minute period . - Written inform consent patient - ≥18 year age - Parity five less singleton pregnancy - ≥36 week gestation - Unfavourable cervix ( baseline modify Bishop score ≤6 ) Misoprostol 200mcg VDS contraindicate accord SmPC follow case : - When hypersensitivity active substance excipients - When labour start - When oxytocic drug and/or labour induction agent give - When suspicion evidence uterine scar result previous uterine surgery , e.g . C-section - When uterine abnormality ( e.g . bicornate uterus ) - When placenta praevia unexplained vaginal bleeding 24 week gestation pregnancy - When foetal malpresentation - When sign symptoms chorioamnionitis , unless adequate prior treatment institute - Before week 36 gestation For evaluation primary secondary endpoint study , descriptive statistical method use .</detailed_description>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>gynaecologist 's indication induction inform consent &gt; 37 week gestation singleton pregnancies cephalic presentation cervical Bishop score &lt; 5 prim reassure fetal heart rate know hypersensitivity prostaglandins uterine scar parity &gt; 5 contraindication vaginal delivery cephalopelvic disproportion placenta previa chorioamnionitis antepartum bleed unknown aetiology cardiopulmonary , renal , hepatic maternal disease glaucoma fetal congenital abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>